Head-to-head · free

Quoin Pharmaceuticals vs Rapport Therapeutics

QNRX vs RAPP — return on capital, cash generation, margins and balance sheet side by side.

QNRX

2 / 3

measures where QNRX leads

RAPP

1 / 3

measures where RAPP leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureQNRX · FY2025RAPP · FY2025
Revenue——
Net income(15.8M)(111.5M)
Revenue growth (yearly, multi-year)——
Free cash flow—(88.1M)
Free cash flow margin——
Net cash / (debt)——
ROIC——
Return on equity-141.6%-28.2%
Gross margin——
Operating margin——
Net debt / EBITDA0.24x0.42x

Figures are as reported by each company; latest fiscal year shown.

Where Quoin Pharmaceuticals's cash went (FY2025)

Capital spending
—
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full QNRX profile →

Where Rapport Therapeutics's cash went (FY2025)

Capital spending
$616000
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full RAPP profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons